News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TELA Bio, Inc. - Common stock
(NQ:
TELA
)
0.6701
-0.0760 (-10.19%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about TELA Bio, Inc. - Common stock
< Previous
1
2
3
4
5
6
Next >
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
October 24, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 23, 2024
Via
Benzinga
Demystifying TELA Bio: Insights From 6 Analyst Reviews
↗
October 04, 2024
Via
Benzinga
Recap: TELA Bio Q4 Earnings
↗
March 21, 2024
Via
Benzinga
Preview: TELA Bio's Earnings
↗
March 20, 2024
Via
Benzinga
TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
October 23, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 22, 2024
Via
Benzinga
TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
October 22, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Third Quarter 2024 Financial Results
October 17, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
Crude Oil Down 2%; Paysafe Shares Surge After Q2 Results
↗
August 13, 2024
Via
Benzinga
S&P 500 Gains 1%; Home Depot Earnings Top Views
↗
August 13, 2024
Via
Benzinga
Topics
Stocks
Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July
↗
August 13, 2024
Via
Benzinga
TELA Stock Earnings: TELA Bio Misses EPS, Misses Revenue for Q2 2024
↗
August 12, 2024
TELA stock results show that TELA Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance
August 12, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
July 25, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Second Quarter 2024 Financial Results
July 22, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
June 04, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
May 20, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q1 2024
↗
May 09, 2024
TELA stock results show that TELA Bio missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
May 09, 2024
Via
Benzinga
TELA Bio Reports First Quarter 2024 Financial Results
May 09, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce First Quarter 2024 Financial Results
April 25, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
April 15, 2024
Targets the more than 665,000 inguinal hernia procedures performed annually in the United States (U.S.)
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
April 08, 2024
Howard N. Langstein, MD, FACS joins innovative MedTech company to leverage his vast experience to help other surgeons optimize clinical outcomes in plastic and reconstructive surgery
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q4 2023
↗
March 21, 2024
TELA stock results show that TELA Bio missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
March 21, 2024
Strong and secure, LIQUIFIX is the first approved adhesive-based product to affix mesh without penetrating patient tissue
From
TELA Bio, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 21, 2024
↗
March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
